Dr. Syed Saoud Zaidi currently serves as an Assistant Professor of Pharmaceutics at the Dow College of Pharmacy of the Dow University of Health Sciences in Karachi Pakistan. He completed his doctoral degree in Pharmaceutics from the University of Florida, (UF), USA in 2017 on Fulbright scholarship. During his time at the UF, he has been mentored by two of the most eminent scientists of this time in the field of biopharmaceutics, Dr. Hartmut Darendorf and Dr. Günther Hochhaus. As a doctoral student with Dr. Hochhaus, his research was focused Pharmacokinetics of inhaled corticosteroids in pregnant mice and identification of the role of P-gp at the Blood Brain Barrier and the fetoplacental barrier in restricting access of steroids in the fetus and maternal organs. He single-handedly designed and executed AstraZeneca’s sponsored research project on the use of Budesonide (BUD) and Fluticasone propionate (FP) in pregnant mice for which he developed a novel protocol for the determination of free and total concentration of BUD and FP in timed pregnant mice and fetus. His work has recently been accepted for publication in the well-reputed journal of the American Association of Pharmaceutical Scientists (The AAPS Journal). Some of his work is under review for publication in many other prestigious journals. His academic training and research experience have equipped him with practical skills in multiple disciplines including pharmacokinetic/pharmacodynamic modeling and simulations, pharmaceutical gene delivery, drug delivery, Pharmacokinetics studies, and analytical chemistry.
Dr. Syed Saoud Zaidi research interests revolve around conducting pharmacokinetics studies in pregnant rodents; developing novel methods to determine free drug concentration of corticosteroids in the most protected sanctuaries i.e. brain, fetus, understanding risk and consequences of fetal exposure of steroids, and exploring the role of efflux transporters at blood-brain barrier and feto-placental barrier.